Comparative investigation of human amniotic epithelial cells and mesenchymal stem cells for application in bone tissue engineering
Jiawen Si, Jiewen Dai, Jianjun Zhang, Sha Liu, Jing Gu, Jun Shi, Steve G F Shen, Lihe Guo, Jiawen Si, Jiewen Dai, Jianjun Zhang, Sha Liu, Jing Gu, Jun Shi, Steve G F Shen, Lihe Guo
Abstract
Emerging evidence suggests amniotic epithelial cells (AECs) as a promising source of progenitor cells in regenerative medicine and bone tissue engineering. However, investigations comparing the regenerative properties of AECs with other sources of stem cells are particularly needed before the feasibility of AECs in bone tissue engineering can be determined. This study aimed to compare human amniotic epithelial cells (hAECs), human bone marrow mesenchymal stem cells (hBMSCs), and human amniotic fluid derived mesenchymal stem cells (hAFMSCs) in terms of their morphology, proliferation, immunophenotype profile, and osteogenic capacity in vitro and in vivo. Not only greatly distinguished by cell morphology and proliferation, hAECs, hAFMSCs, and hBMSCs exhibited remarkably different signature regarding immunophenotypical profile. Microarray analysis revealed a different expression profile of genes involved in ossification along the three cell sources, highlighting the impact of different anatomical origin and molecular response to osteogenic induction on the final tissue-forming potential. Furthermore, our data indicated a potential role of FOXC2 in early osteogenic commitment.
Figures
References
- Marolt D., Campos I. M., Bhumiratana S., et al. Engineering bone tissue from human embryonic stem cells. Proceedings of the National Academy of Sciences of the United States of America. 2012;109(22):8705–8709. doi: 10.1073/pnas.1201830109.
- de Peppo G. M., Marcos-Campos I., Kahler D. J., et al. Engineering bone tissue substitutes from human induced pluripotent stem cells. Proceedings of the National Academy of Sciences of the United States of America. 2013;110(21):8680–8685. doi: 10.1073/pnas.1301190110.
- Behnia H., Khojasteh A., Soleimani M., Tehranchi A., Atashi A. Repair of alveolar cleft defect with mesenchymal stem cells and platelet derived growth factors: a preliminary report. Journal of Cranio-Maxillofacial Surgery. 2012;40(1):2–7. doi: 10.1016/j.jcms.2011.02.003.
- Kaigler D., Pagni G., Park C. H., et al. Stem cell therapy for craniofacial bone regeneration: a randomized, controlled feasibility trial. Cell Transplantation. 2013;22(5):767–777. doi: 10.3727/096368912x652968.
- Yang H., Gao L.-N., An Y., et al. Comparison of mesenchymal stem cells derived from gingival tissue and periodontal ligament in different incubation conditions. Biomaterials. 2013;34(29):7033–7047. doi: 10.1016/j.biomaterials.2013.05.025.
- Zhang W., Zhang X., Wang S., et al. Comparison of the use of adipose tissue-derived and bone marrow-derived stem cells for rapid bone regeneration. Journal of Dental Research. 2013;92(12):1136–1141. doi: 10.1177/0022034513507581.
- Peister A., Woodruff M. A., Prince J. J., Gray D. P., Hutmacher D. W., Guldberg R. E. Cell sourcing for bone tissue engineering: amniotic fluid stem cells have a delayed, robust differentiation compared to mesenchymal stem cells. Stem Cell Research. 2011;7(1):17–27. doi: 10.1016/j.scr.2011.03.001.
- Rodrigues M. T., Lee S. J., Gomes M. E., Reis R. L., Atala A., Yoo J. J. Amniotic fluid-derived stem cells as a cell source for bone tissue engineering. Tissue Engineering, Part A. 2012;18(23-24):2518–2527. doi: 10.1089/ten.tea.2011.0672.
- Bačenková D., Rosocha J., Tóthová T., Rosocha L., Šarissk M. Isolation and basic characterization of human term amnion and chorion mesenchymal stromal cells. Cytotherapy. 2011;13(9):1047–1056. doi: 10.3109/14653249.2011.592522.
- Sidney L. E., Kirkham G. R., Buttery L. D. Comparison of osteogenic differentiation of embryonic stem cells and primary osteoblasts revealed by responses to IL-1β, TNF-α, and IFN-γ . Stem Cells and Development. 2014;23(6):605–617. doi: 10.1089/scd.2013.0336.
- Bilic G., Zeisberger S. M., Mallik A. S., Zimmermann R., Zisch A. H. Comparative characterization of cultured human term amnion epithelial and mesenchymal stromal cells for application in cell therapy. Cell Transplantation. 2008;17(8):955–968. doi: 10.3727/096368908786576507.
- Ilancheran S., Moodley Y., Manuelpillai U. Human fetal membranes: a source of stem cells for tissue regeneration and repair? Placenta. 2009;30(1):2–10. doi: 10.1016/j.placenta.2008.09.009.
- Dobreva M. P., Pereira P. N. G., Deprest J., Zwijsen A. On the origin of amniotic stem cells: of mice and men. International Journal of Developmental Biology. 2010;54(5):761–777. doi: 10.1387/ijdb.092935md.
- Miki T., Lehmann T., Cai H., Stolz D. B., Strom S. C. Stem cell characteristics of amniotic epithelial cells. Stem Cells. 2005;23(10):1549–1559. doi: 10.1634/stemcells.2004-0357.
- Barboni B., Mangano C., Valbonetti L., et al. Synthetic bone substitute engineered with amniotic epithelial cells enhances bone regeneration after maxillary sinus augmentation. PLoS ONE. 2013;8(5) doi: 10.1371/journal.pone.0063256.e63256
- Wolbank S., van Griensven M., Grillari-Voglauer R., Peterbauer-Scherb A. Alternative sources of adult stem cells: human amniotic membrane. Advances in Biochemical Engineering/Biotechnology. 2010;123:1–27. doi: 10.1007/10_2010_71.
- Zhou J., Yu G., Cao C., Pang J., Chen X. Bone morphogenetic protein-7 promotes chondrogenesis in human amniotic epithelial cells. International Orthopaedics. 2011;35(6):941–948. doi: 10.1007/s00264-010-1116-3.
- Mattioli M., Gloria A., Turriani M., et al. Stemness characteristics and osteogenic potential of sheep amniotic epithelial cells. Cell Biology International. 2012;36(1):7–19. doi: 10.1042/CBI20100720.
- Yuan J., Cao Y., Liu W. Biomimetic scaffolds: implications for craniofacial regeneration. Journal of Craniofacial Surgery. 2012;23(1):294–297. doi: 10.1097/scs.0b013e318241bae1.
- Qureshi K. M., Oliver R. J., Paget M. B., Murray H. E., Bailey C. J., Downing R. Human amniotic epithelial cells induce localized cell-mediated immune privilege in vitro: Implications for pancreatic islet transplantation. Cell Transplantation. 2011;20(4):523–534. doi: 10.3727/096368910X528111.
- Wolbank S., Peterbauer A., Fahrner M., et al. Dose-dependent immunomodulatory effect of human stem cells from amniotic membrane: a comparison with human mesenchymal stem cells from adipose tissue. Tissue Engineering. 2007;13(6):1173–1183. doi: 10.1089/ten.2006.0313.
- Stadler G., Hennerbichler S., Lindenmair A., et al. Phenotypic shift of human amniotic epithelial cells in culture is associated with reduced osteogenic differentiation in vitro. Cytotherapy. 2008;10(7):743–752. doi: 10.1080/14653240802345804.
- Liu T., Zou G., Gao Y., et al. High efficiency of reprogramming CD34+ cells derived from human amniotic fluid into induced pluripotent stem cells with oct4. Stem Cells and Development. 2012;21(12):2322–2332. doi: 10.1089/scd.2011.0715.
- Jiawen S., Jianjun Z., Jiewen D., et al. Osteogenic differentiation of human amniotic epithelial cells and its application in alveolar defect restoration. Stem Cells Translational Medicine. 2014;3(12):1504–1513. doi: 10.5966/sctm.2014-0118.
- Si J., Zhang J., Liu S., et al. Characterization of a micro-roughened TiO2/ZrO2 coating: mechanical properties and HBMSC responses in vitro. Acta Biochimica et Biophysica Sinica. 2014;46(7):572–581. doi: 10.1093/abbs/gmu040.
- Tan F., Naciri M., Dowling D., Al-Rubeai M. In vitro and in vivo bioactivity of CoBlast hydroxyapatite coating and the effect of impaction on its osteoconductivity. Biotechnology Advances. 2012;30(1):352–362. doi: 10.1016/j.biotechadv.2011.07.008.
- Wang F., Yu M., Yan X., et al. Gingiva-derived mesenchymal stem cell-mediated therapeutic approach for bone tissue regeneration. Stem Cells and Development. 2011;20(12):2093–2102. doi: 10.1089/scd.2010.0523.
- Park D., Spencer J. A., Koh B. I., et al. Endogenous bone marrow MSCs are dynamic, fate-restricted participants in bone maintenance and regeneration. Cell Stem Cell. 2012;10(3):259–272. doi: 10.1016/j.stem.2012.02.003.
- Parolini O., Alviano F., Bagnara G. P., et al. Concise review: isolation and characterization of cells from human term placenta: outcome of the first international Workshop on Placenta Derived Stem Cells. Stem Cells. 2008;26(2):300–311. doi: 10.1634/stemcells.2007-0594.
- Parolini O., Soncini M. Regenerative Medicine Using Pregnancy-Specific Biological Substances. London, UK: Springer; 2011. Placenta as a source of stem cells and as a key organ for fetomaternal tolerance; pp. 11–23.
- Banas R. A., Trumpower C., Bentlejewski C., Marshall V., Sing G., Zeevi A. Immunogenicity and immunomodulatory effects of amnion-derived multipotent progenitor cells. Human Immunology. 2008;69(6):321–328. doi: 10.1016/j.humimm.2008.04.007.
- Lim R., Chan S. T., Tan J. L., Mockler J. C., Murphy S. V., Wallace E. M. Preterm human amnion epithelial cells have limited reparative potential. Placenta. 2013;34(6):486–492. doi: 10.1016/j.placenta.2013.03.010.
- Riccio M., Maraldi T., Pisciotta A., et al. Fibroin scaffold repairs critical-size bone defects in vivo supported by human amniotic fluid and dental pulp stem cells. Tissue Engineering—Part A. 2012;18(9-10):1006–1013. doi: 10.1089/ten.tea.2011.0542.
- Maraldi T., Riccio M., Resca E., et al. Human amniotic fluid stem cells seeded in fibroin scaffold produce in vivo mineralized matrix. Tissue Engineering Part A. 2011;17(21-22):2833–2843. doi: 10.1089/ten.tea.2011.0062.
- Rodrigues M. T., Lee B. K., Lee S. J., et al. The effect of differentiation stage of amniotic fluid stem cells on bone regeneration. Biomaterials. 2012;33(26):6069–6078. doi: 10.1016/j.biomaterials.2012.05.016.
- Bianco P. Bone and the hematopoietic niche: a tale of two stem cells. Blood. 2011;117(20):5281–5288. doi: 10.1182/blood-2011-01-315069.
- Keating A. Mesenchymal stromal cells: new directions. Cell Stem Cell. 2012;10(6):709–716. doi: 10.1016/j.stem.2012.05.015.
- Schofield R. The relationship between the spleen colony-forming cell and the haemopoietic stem cell. Blood Cells. 1978;4(1-2):7–25.
- Lane S. W., Williams D. A., Watt F. M. Modulating the stem cell niche for tissue regeneration. Nature Biotechnology. 2014;32(8):795–803. doi: 10.1038/nbt.2978.
- Nifuji A., Miura N., Kato N., Kellermann O., Noda M. Bone morphogenetic protein regulation of forkhead/winged helix transcription factor Foxc2 (Mfh1) in a murine mesodermal cell line C1 and in skeletal precursor cells. Journal of Bone and Mineral Research. 2001;16(10):1765–1771. doi: 10.1359/jbmr.2001.16.10.1765.
- Yang X.-L., Matsuura H., Fu Y., Sugiyama T., Miura N. MFH-1 is required for bone morphogenetic protein-2-induced osteoblastic differentiation of C2C12 myoblasts. FEBS Letters. 2000;470(1):29–34. doi: 10.1016/s0014-5793(00)01285-0.
- Iida K., Koseki H., Kakinuma H., et al. Essential roles of the winged helix transcription factor MFH-1 in aortic arch patterning and skeletogenesis. Development. 1997;124(22):4627–4638.
- Park S. J., Gadi J., Cho K. W., et al. The forkhead transcription factor Foxc2 promotes osteoblastogenesis via up-regulation of integrin beta1 expression. Bone. 2011;49(3):428–438. doi: 10.1016/j.bone.2011.05.012.
- You W., Gao H., Fan L., Duan D., Wang C., Wang K. Foxc2 regulates osteogenesis and angiogenesis of bone marrow mesenchymal stem cells. BMC Musculoskeletal Disorders. 2013;14, article 199 doi: 10.1186/1471-2474-14-199.
- Ozturk F., Li Y., Zhu X., Guda C., Nawshad A. Systematic analysis of palatal transcriptome to identify cleft palate genes within TGFβ3-knockout mice alleles: RNA-Seq analysis of TGFβ3 Mice. BMC Genomics. 2013;14(1, article 113) doi: 10.1186/1471-2164-14-113.
- You W., Fan L., Duan D., et al. Foxc2 over-expression in bone marrow mesenchymal stem cells stimulates osteogenic differentiation and inhibits adipogenic differentiation. Molecular and Cellular Biochemistry. 2014;386(1-2):125–134. doi: 10.1007/s11010-013-1851-z.
- Yamada Y., Ando F., Shimokata H. Association of polymorphisms in forkhead box C2 and perilipin genes with bone mineral density in community-dwelling Japanese individuals. International Journal of Molecular Medicine. 2006;18(1):119–127. doi: 10.3892/ijmm.18.1.119.
- Davis K. E., Moldes M., Farmer S. R. The forkhead transcription factor FoxC2 inhibits white adipocyte differentiation. The Journal of Biological Chemistry. 2004;279(41):42453–42461. doi: 10.1074/jbc.m402197200.
- Seo B.-M., Miura M., Gronthos S., et al. Investigation of multipotent postnatal stem cells from human periodontal ligament. The Lancet. 2004;364(9429):149–155. doi: 10.1016/s0140-6736(04)16627-0.
- Gronthos S., Mankani M., Brahim J., Robey P. G., Shi S. Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proceedings of the National Academy of Sciences of the United States of America. 2000;97(25):13625–13630. doi: 10.1073/pnas.240309797.
- Hough S. R., Thornton M., Mason E., Mar J. C., Wells C. A., Pera M. F. Single-cell gene expression profiles define self-renewing, pluripotent, and lineage primed states of human pluripotent stem cells. Stem Cell Reports. 2014;2(6):881–895. doi: 10.1016/j.stemcr.2014.04.014.
Source: PubMed